News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
789,724 Results
Type
Article (56794)
Company Profile (535)
Press Release (732379)
Multimedia
Podcasts (157)
Webinars (22)
Section
Business (220540)
Career Advice (2908)
Deals (38100)
Drug Delivery (141)
Drug Development (87915)
Employer Resources (186)
FDA (17647)
Job Trends (16333)
News (375135)
Policy (36507)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2938)
Academic (1)
Accelerated approval (34)
Adcomms (34)
Allergies (148)
Alliances (54148)
ALS (181)
Alzheimer's disease (1778)
Antibody-drug conjugate (ADC) (341)
Approvals (17834)
Artificial intelligence (571)
Autoimmune disease (156)
Automation (37)
Bankruptcy (393)
Best Places to Work (12333)
BIOSECURE Act (21)
Biosimilars (201)
Biotechnology (348)
Bladder cancer (163)
Brain cancer (62)
Breast cancer (664)
Cancer (5012)
Cardiovascular disease (439)
Career advice (2463)
Career pathing (41)
CAR-T (297)
CDC (54)
Celiac Disease (2)
Cell therapy (791)
Cervical cancer (36)
Clinical research (74458)
Collaboration (1817)
Company closure (4)
Compensation (1153)
Complete response letters (71)
COVID-19 (2946)
CRISPR (99)
C-suite (870)
Cystic fibrosis (153)
Data (6268)
Decentralized trials (2)
Denatured (51)
Depression (149)
Diabetes (523)
Diagnostics (7068)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (269)
Drug pricing (219)
Drug shortages (33)
Duchenne muscular dystrophy (239)
Earnings (94031)
Editorial (64)
Employer branding (23)
Employer resources (163)
Events (127237)
Executive appointments (1029)
FDA (20803)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1535)
Gene editing (214)
Generative AI (50)
Gene therapy (654)
GLP-1 (1094)
Government (5202)
Grass and pollen (8)
Guidances (385)
Healthcare (20330)
HIV (61)
Huntington's disease (47)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (60)
Indications (100)
Infectious disease (3226)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (248)
Interviews (559)
IPO (17408)
IRA (60)
Job creations (4381)
Job search strategy (2008)
JPM (69)
Kidney cancer (17)
Labor market (83)
Layoffs (631)
Leadership (40)
Legal (9043)
Liver cancer (99)
Longevity (15)
Lung cancer (677)
Lymphoma (379)
Machine learning (44)
Management (64)
Manufacturing (828)
MASH (174)
Medical device (14508)
Medtech (14560)
Mergers & acquisitions (21748)
Metabolic disorders (1372)
Multiple sclerosis (163)
NASH (23)
Neurodegenerative disease (347)
Neuropsychiatric disorders (100)
Neuroscience (3087)
Neurotech (1)
NextGen: Class of 2026 (7305)
Non-profit (4943)
Now hiring (65)
Obesity (660)
Opinion (321)
Ovarian cancer (166)
Pain (214)
Pancreatic cancer (230)
Parkinson's disease (298)
Partnered (35)
Patents (507)
Patient recruitment (488)
Peanut (60)
People (64502)
Pharmaceutical (111)
Pharmacy benefit managers (32)
Phase 1 (23154)
Phase 2 (32615)
Phase 3 (24404)
Pipeline (5125)
Policy (327)
Postmarket research (2991)
Preclinical (9971)
Press Release (71)
Prostate cancer (247)
Psychedelics (56)
Radiopharmaceuticals (298)
Rare diseases (905)
Real estate (6688)
Recruiting (76)
Regulatory (26889)
Reports (52)
Research institute (2660)
Resumes & cover letters (457)
Rett syndrome (28)
RNA editing (20)
RSV (80)
Schizophrenia (159)
Series A (255)
Series B (196)
Service/supplier (13)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (44)
Startups (4018)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (99)
The Weekly (104)
Vaccines (1109)
Venture capital (96)
Weight loss (449)
Women's health (87)
Worklife (21)
Date
Today (113)
Last 7 days (550)
Last 30 days (2513)
Last 365 days (31656)
2026 (2692)
2025 (32043)
2024 (37307)
2023 (42073)
2022 (53381)
2021 (58050)
2020 (56802)
2019 (50097)
2018 (37939)
2017 (35108)
2016 (35048)
2015 (41124)
2014 (35331)
2013 (30699)
2012 (32649)
2011 (33128)
2010 (31429)
Location
Africa (970)
Alabama (90)
Alaska (7)
Arizona (324)
Arkansas (14)
Asia (45932)
Australia (8057)
California (11451)
Canada (3300)
China (1160)
Colorado (482)
Connecticut (495)
Delaware (341)
Europe (101646)
Florida (1670)
Georgia (362)
Hawaii (3)
Idaho (65)
Illinois (921)
India (66)
Indiana (531)
Iowa (24)
Japan (428)
Kansas (130)
Kentucky (42)
Louisiana (26)
Maine (72)
Maryland (1436)
Massachusetts (8353)
Michigan (331)
Minnesota (651)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (28)
Nevada (123)
New Hampshire (85)
New Jersey (3068)
New Mexico (32)
New York (3021)
North Carolina (1566)
North Dakota (9)
Northern California (5524)
Ohio (336)
Oklahoma (21)
Oregon (48)
Pennsylvania (2299)
Puerto Rico (23)
Rhode Island (50)
South America (1347)
South Carolina (64)
South Dakota (1)
Southern California (4442)
Tennessee (176)
Texas (1776)
United States (41023)
Utah (343)
Vermont (1)
Virginia (282)
Washington D.C. (86)
Washington State (956)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
789,724 Results for "melinta therapeutics formerly known as rib x pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals
January 12, 2026
·
2 min read
Press Releases
Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership
August 7, 2025
·
7 min read
Press Releases
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
September 3, 2025
·
12 min read
Press Releases
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
August 7, 2025
·
11 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)
January 13, 2026
·
9 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Tanabe Pharma America Announces Positive Topline Results for Dersimelagon in Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
January 21, 2026
·
5 min read
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
1 of 78,973
Next
